|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Kala Pharmaceuticals, Inc.
| | | Phone: | (781) 996-5252 | Fax: | (781) 642-0399 | Year Established: | 2009 | Ticker: | KALA | Exchange: | NASDAQ | Main Contact: | Mark Iwicki, Chairman & CEO | | Other Contacts: | Eric Trachtenberg, General Counsel Michele LaRussa, Senior VP, RA & QA Mary Reumuth, C.P.A., CFO Hongming Chen, ScD, CSO Kim Brazzell, PhD, CMO Todd Bazemore, COO Vincent Kosewski, Senior VP, Manufacturing and Supply Chain Management Steven Zhang, VP, Medical Affairs
| | Company Description | Kala is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary mucus-penetrating particle (MPP) technology, with an initial focus on the treatment of eye diseases. Kala has applied the MPP technology to a corticosteroid designed for ocular applications, resulting in two lead product candidates. | |
|
|
|
|
|